	Oncological Safety of Bladder Preservation in Elderly Patients with Muscle-Invasive Bladder Cancer. Ann Surg Oncol Mehmud I, Zhang Y, Wu S, Zhang S. PMID: 41649780 [PubMed - as supplied by publisher]
	[Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may the urinary bladder be preserved?]. Urologie Bolenz C, Zengerling F, Kübler H, Hahn O. PMID: 41649558 [PubMed - as supplied by publisher]
	[Current diagnostics and treatment of penile cancer]. Urologie Dräger DL, Protzel C. PMID: 41649557 [PubMed - as supplied by publisher]
	The use of computed tomography during follow-up after ablation of cT1 renal cell carcinoma: evidence for overuse. Eur Radiol Reijerink MAA, van den Brink L, Henderickx MMEL, van Delden OM, Beerlage HP, Bex A, Jamaludin FS, Shahraki MN, Zondervan PJ, Stoker J. PMID: 41649536 [PubMed - as supplied by publisher]
	A Novel Method to Generate Analyte-Specific Specimens for Multi-Omic Studies of Primary Bladder Cancer. Biopreserv Biobank Mojica W, Izydorczak A, Wood T, Hsu J, Wu Y. PMID: 41649158 [PubMed - as supplied by publisher]
	Roles of E3 ubiquitin ligases and deubiquitinating enzymes in renal cell carcinoma. Front Oncol Jiang M, Si W, Huang S, Qu S, Zhang M, Quan Y. PMID: 41647837 [PubMed]
	Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohort. ESMO Real World Data Digit Oncol George G, Rowley M, Coolen ACC, Santa Olalla A, Hammar N, Feychting M, Karagiannis SN, Enting D, Van Hemelrijck M. PMID: 41647707 [PubMed]
	Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study. ESMO Real World Data Digit Oncol Tran B, Yeh N, Gayle A, Holmes E, Hu J, Damineni S, Kebede N, Shore N. PMID: 41647700 [PubMed]
	Cost-effectiveness analysis of a biopsy-free diagnostic strategy for prostate cancer using mpMRI and PSMA-PET/CT. BJUI Compass Tung JYM, Lau RS, Teo EPS, Chow KM, Ong JHW, Lu TS, Chen W, Li J, Yang X, Lee AY, Tan YG, Tay KJ, Thang SP, Lam WWC, Law YM, Ho HSS, Cheng CWS, Yuen JS, Chen K. PMID: 41647483 [PubMed]
	Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing. Front Immunol Ning W, Chang P, Zheng J, Chen W. PMID: 41646982 [PubMed - indexed for MEDLINE]
	Identification and diagnostic evaluation of an aptamer targeting prostate-cancer-derived small extracellular vesicles. Mol Ther Nucleic Acids Ding T, Li Y, Xue L, Xiong C, Yu L, He Q, Liu J, Hao X, Zhao D. PMID: 41646885 [PubMed]
	Effect of implementing population-based prostate-specific antigen screening on testing rates and prostate cancer overdiagnosis in England: a statistical modelling study. medRxiv Vickers AJ, Brentnall A. PMID: 41646809 [PubMed]
	Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trial. medRxiv Brentnall AR, Rebolj M, Sasieni P, Funston G, Gabe R, Vickers A. PMID: 41646805 [PubMed]
	Radio-pathomic maps of histo-morphometric features trained with whole mount prostate histology distinguish prostate cancer on MP-MRI. medRxiv Duenweg SR, Bobholz SA, Lowman AK, Winiarz A, Nath B, Barrett MJ, Kyereme F, Vincent-Sheldon S, Bhatt K, Troy K, Kim M, Fair E, Iczkowski KA, Jacobsohn KM, Banerjee A, Hall WA, Nencka AS, LaViolette PS. PMID: 41646780 [PubMed]
	Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study. ESMO Real World Data Digit Oncol Barthelemy P, Thiery-Vuillemin A, Lebret T, Bigot P, Stein U, Dourthe LM, Longo R, Gimel P, Auberger B, De La Cruz J, Malak D, Samia Z, Texier N, Albiges L. PMID: 41646210 [PubMed]
	The Promise of Mindfulness-Based Interventions: A Stress-Reduction Strategy for Testicular Cancer Survivors' Health-Related Quality of Life. Cancer Med Rovito MJ, O'Mahony CF, Thomas K, Brazendale K, Fairman CM. PMID: 41645861 [PubMed - indexed for MEDLINE]
	Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy. Cancer Lane BR, Lewicki P, Noyes SL, Labardee C, Meah S, Daignault-Newton S, Hafron J, Morgan TM, Radhakrishnan A, Dess RT, Montie J, Ghani KR, Ginsburg KB, Borza T. PMID: 41645394 [PubMed - indexed for MEDLINE]
	Preoperative Multiparametric MRI-Based Tumour-Periprostatic Adipose Tissue Interface Characterisation for Extraprostatic Extension Prediction in Prostate Cancer. Cancer Med Zhang S, Huo L, Zhu Z, Wan J, Xu L, Xia J, Xu Y, Liu J, Zhao Y. PMID: 41645030 [PubMed - indexed for MEDLINE]
	Application and prospect of artificial intelligence in diagnostic imaging of prostate cancer. NPJ Digit Med Wang X, Zhong S, Fang K, Du Y, Huang J. PMID: 41644780 [PubMed - as supplied by publisher]
	Psychosocial experience of couples coping with prostate cancer: a qualitative study. Sci Rep Yuan X, Yu Z, Yin H, Yang Z, Chen M, Yang Y. PMID: 41644674 [PubMed - as supplied by publisher]

Articles 1 - 20 / 175795

Page 1 of 8790



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy